CD36 and cancer: Anecdotally the PUR-4 signature for RPx4 which was found to have an area of GP4+5 on RPx was much higher than expected for the volume of GP4 calculated in this largely GG2 < 10% GP4 cancer, which may imply that PUR-4 can respond to disease that is becoming more aggressive.